- Home
- UGRO vs ALBT Comparison
UGRO vs ALBT Comparison
Compare UGRO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- ALBT
- Stock Information
- Founded
- UGRO 2014
- ALBT 2014
- Country
- UGRO United States
- ALBT United States
- Employees
- UGRO N/A
- ALBT N/A
- Industry
- UGRO Industrial Specialties
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UGRO Consumer Discretionary
- ALBT Health Care
- Exchange
- UGRO Nasdaq
- ALBT Nasdaq
- Market Cap
- UGRO 5.5M
- ALBT 5.3M
- IPO Year
- UGRO N/A
- ALBT N/A
- Fundamental
- Price
- UGRO $0.39
- ALBT $3.41
- Analyst Decision
- UGRO Strong Buy
- ALBT
- Analyst Count
- UGRO 1
- ALBT 0
- Target Price
- UGRO $3.00
- ALBT N/A
- AVG Volume (30 Days)
- UGRO 117.3K
- ALBT 12.3K
- Earning Date
- UGRO 06-17-2025
- ALBT 05-13-2025
- Dividend Yield
- UGRO N/A
- ALBT N/A
- EPS Growth
- UGRO N/A
- ALBT N/A
- EPS
- UGRO N/A
- ALBT N/A
- Revenue
- UGRO $59,985,133.00
- ALBT $807,235.00
- Revenue This Year
- UGRO N/A
- ALBT N/A
- Revenue Next Year
- UGRO $31.25
- ALBT N/A
- P/E Ratio
- UGRO N/A
- ALBT N/A
- Revenue Growth
- UGRO N/A
- ALBT N/A
- 52 Week Low
- UGRO $0.29
- ALBT $2.11
- 52 Week High
- UGRO $1.92
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- UGRO 49.87
- ALBT 37.21
- Support Level
- UGRO $0.29
- ALBT $3.40
- Resistance Level
- UGRO $0.42
- ALBT $3.79
- Average True Range (ATR)
- UGRO 0.03
- ALBT 0.19
- MACD
- UGRO 0.01
- ALBT -0.02
- Stochastic Oscillator
- UGRO 76.92
- ALBT 1.83
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.